Document is current

Any future updates will be listed below

Correction to: Durvalumab: A Review in Extensive-Stage SCLC

Crossref DOI link: https://doi.org/10.1007/S11523-021-00863-W

Published Online: 2021-12-06

Published Print: 2022-01

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark